AEM vs HWKN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.
Hawkins, Inc. exhibits exceptional financial health with a perfect Piotroski F-Score of 9/9, indicating a fortress-like balance sheet and strong operational efficiency. However, the stock is severely overvalued from a deterministic standpoint, trading at $148.10—well above its Graham Number ($47.15) and Intrinsic Value ($76.23). While long-term performance is stellar (+370% over 5 years), current YoY revenue growth is slightly negative (-1.60%) and the technical trend is bearish. The company is a high-quality asset currently priced for perfection, creating a significant gap between fundamental value and market price.
Compare Another Pair
Related Comparisons
AEM vs HWKN: Head-to-Head Comparison
This page compares Agnico Eagle Mines Limited (AEM) and Hawkins, Inc. (HWKN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.